Mental Health Screening Market: Growth, Size, Share, and Trends

Market Growth Outlook Summary

The global mental health screening market, valued at US$0.8 billion in 2022, is forecasted to grow at a robust CAGR of 12.2%, reaching US$0.9 billion in 2023 and an impressive US$1.8 billion by 2029. Mental health screening refers to the process of assessing an individual’s mental health status to identify potential signs or symptoms of mental health conditions. It is a preliminary step in recognizing and addressing mental health concerns early on. The goal of mental health screening is to identify individuals who may be at risk of or experiencing mental health issues so that appropriate interventions, support, or further assessments can be provided. The growth of this market is driven by the rising awareness of mental health issues, growing geriatric population and subsequent increase in the prevalence of mental disorders, and technological advancements. However, the concerns regarding accuracy and validity of the screening platforms inhibits the market growth.

Mental Health Screening Market Trends

To know about the assumptions considered for the study, Request for Free Sample Report

Mental Health Screening Market Dynamics

DRIVER: Rising awareness of mental health issues

The growing awareness about mental health issues has been a significant driving force behind the increased adoption of mental health screening tools and solutions. In the past decade, there has been a notable shift in societal attitudes towards mental health, with heightened recognition of its prevalence and impact.

• According to the World Health Organization (WHO), in 2019, approximately 1 in every 8 people (970 million people) worldwide were living with a mental disorder.
• Initiatives like "Bell Let's Talk" in Canada and "Mental Health Awareness Month" in the US have gained widespread traction, fostering dialog and encouraging individuals to seek support.
• According to a Healthy Now survey conducted by Parade Media and Cleveland in 2021, 82% of Americans agree that mental health is just as important as physical health. This represents a notable rise from the 68% who strongly concurred with this sentiment in 2018.
• According to a 2022 survey by the National Alliance on Mental Illness (NAMI), 73% of Americans believe that the stigma surrounding mental illness has decreased in the past five years.

This increased awareness has increased the demand for mental health resources, including screening tools, as individuals seek to proactively manage their well-being.

RESTRAINT: Stigma and limited awareness

The stigma surrounding mental health continues to be a significant barrier to the widespread adoption and effective utilization of mental health screening tools and solutions. Despite efforts to raise awareness and reduce this stigma, societal misconceptions and negative attitudes towards mental illness persist, hindering individuals from seeking help and utilizing screening resources.

A 2023 survey by NAMI found that 44% of Americans with mental illness reported experiencing discrimination due to their condition. This stigma often creates a significant barrier to individuals seeking help. Fear of judgment, discrimination, and negative consequences often leads to avoidance of screening and treatment, delaying interventions and potentially worsening symptoms. This exacerbates the severity of mental health conditions and reduces the effectiveness of screening interventions.

Moreover, limited awareness about mental health and available screening tools further contributes to the underutilization of mental health resources. Many individuals may not recognize the signs and symptoms of mental illness or understand the importance of early intervention and screening.

OPPORTUNITY: Rise of social media and its impact on adoption of mental health screening tools

The emergence of social media platforms presents a significant opportunity to increase the adoption and utilization of mental health screening tools and solutions. Social media has become an integral part of the daily lives of billions of people worldwide, offering unprecedented access to information, support networks, and peer communities. According to a 2023 survey by The Trevor Project, 76% of LGBTQ+ youth utilize social media to find information and support regarding mental health. Social media platforms can be powerful tools for spreading awareness about mental health conditions, destigmatizing seeking help, and fostering open conversations. This can encourage individuals to explore screening tools as a means to monitor their well-being. Moreover, social media provides a platform for sharing personal stories, experiences, and testimonials related to mental health, which can help normalize discussions around mental illness and encourage help-seeking behaviors. By harnessing the reach and influence of social media platforms, mental health screening tools and solutions can effectively reach and engage individuals, ultimately improving access to care and promoting early intervention for mental health disorders.

CHALLENGE: Concerns regarding accuracy and validity

One of the most significant challenges facing mental health screening tools and solutions is the concern regarding their accuracy and validity. While these tools aim to provide valuable insights into individuals' mental well-being, there are concerns about their reliability in accurately identifying and assessing mental health conditions. According to a study published in the Journal of the American Medical Association (JAMA), researchers found significant variability in the accuracy of popular mental health screening apps, with some apps demonstrating poor sensitivity and specificity in detecting mental health disorders. Furthermore, there are concerns about the lack of standardized guidelines and validation processes for mental health screening tools. Without rigorous validation and testing procedures, there is a risk that screening tools may produce inconsistent or inaccurate results, leading to false positives or false negatives.

Mental health screening Industry Ecosystem

The mental health screening market ecosystem comprises entities responsible for the end-to-end workflow of screening mental issues.

The stakeholders present in this market include developers and providers of screening tools, telehealth & virtual care platforms, health providers & institutions, health insurance & payer organizations, research & academic institutions, and regulatory & compliance bodies.

DEVELOPERS & PROVIDERS OF SCREENING TOOLS

• These companies design, develop, and distribute mental health screening tools, including apps, software, and digital platforms.
• They offer innovative and accessible tools for early detection and intervention.

TELEHEALTH & VIRTUAL CARE PLATFORMS

• These platforms facilitate remote access to mental health screening, assessment, and counseling services.
• They increase access to care, especially in underserved areas or for individuals with mobility constraints.

HEALTH PROVIDERS & INSTITUTIONS

• These organizations integrate mental health screening tools into their care delivery models.
• They enhance patient care by identifying mental health issues early and connecting individuals with appropriate resources.

HEALTH INSURANCE & PAYER ORGANIZATIONS

• These companies may cover mental health screening services and provide incentives for using certain screening tools.
• They improve affordability and incentivize preventive care, reducing long-term healthcare costs.

RESEARCH & ACADEMIC INSTITUTIONS

• These institutions contribute to developing and validating mental health screening tools through research and clinical trials.
• They conduct research and clinical trials to validate screening tools and advance mental health knowledge.
• They drive innovation, improve tool effectiveness, and contribute to evidence-based practices.

REGULATORY & COMPLIANCE BODIES

• These organizations establish guidelines and standards for developing and using mental health screening tools.
• They ensure quality, safety, and patient privacy, fostering trust in screening tools and promoting responsible use.

Attention deficit hyperactivity disorder (ADHD) is the largest psychiatric disorder of the mental health screening industry in 2022.

Based on applications, the mental health screening market is segmented into physiological, psychiatric, behavioral, and cognitive disorders. Psychiatric disorders are further segmented into schizophrenia, psychotic disorder, dissociative disorder, obsessive compulsive disorder, dissociative disorder, attention deficit hyperactivity disorder (ADHD), and other psychiatric disorders.

Among psychiatric disorders, attention deficit hyperactivity disorder (ADHD) sub-segment dominates the market in 2022, attributing to several factors. The cases and diagnoses of ADHD have been increasing due to growing awareness about ADHD. These factors contribute to an increased demand for ADHD screening.

The self-reported questionnaires & surveys segment is expected to grow at the highest CAGR from 2024 to 2029 in the mental health screening industry.

Based on screening methods, the global mental health screening market is segmented into self-reported questionnaires & surveys, clinical interviews, observation-based assessments, and biomarker testing. The self-reported questionnaires & surveys segment is expected to register the highest growth rate during the forecast period. Wide variety of questionnaires at affordable prices over digital platforms and availability of self-reported questionnaires & surveys in multilingual formats are the key factors driving the adoption of self-reported questionnaire-based assessments in mental health screening.

The online platforms segment is expected to grow at the highest CAGR from 2024 to 2029 in the mental health screening industry.

Based on setting, the Mental Health Screening market is segmented into clinical settings, educational institutions, workplace/corporate programs, online platforms, and other settings. The online platforms segment is expected to register the highest growth rate in the forecast period attributing to the availability of personalized assessments for the mental health status and needs of the users.

North America accounted for the largest share of the mental health screening industry in 2023.

Based on the region, the mental health screening market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America accounted for the largest share of the market in 2023. This is due to the growing number of people requiring mental health services, health reforms in the US, and government funding for mental health services in the region.

To know about the assumptions considered for the study, download the pdf brochure

Prominent players in Mental health screening market include Proem Behavioral Health (US), SonderMind Inc. (US), Riverside Community Care (US), Headspace Health (US), Quartet Health, Inc. (US), Canary Speech, Inc. (US), Sonde Health, Inc. (US), Koninklijke Philips N.V. (Netherlands), Alphabet Inc. (Fitbit) (US), ResMed (US), Apple Inc. (US), Wellin5 USA Inc. (Canada), Clarigent Health (US), Woebot Labs Inc. (US), Aiberry (US), Cognitive Health Solutions, LLC (US), Adaptive Testing Technologies (US), Thymia Limited (UK), Modern Life, Inc. (US), MoodFit (US), MoodTools (US), Kintsugi Mindful Wellness, Inc. (US), Ellipsis Health Inc. (US), FuturesTHRIVE (US), and CogniABle (India).

Scope of the Mental Health Screening Industry

The study categorizes the Mental Health Screening market to forecast revenue and analyze trends in each of the following submarkets:

By Application

• Software
• Services
• Wearables, Mobile and Other Devices
• Physiological Disorders
  • Depression
  • Anxiety
  • Post-Traumatic Stress Disorder (PTSD)
  • Bipolar Disorder
  • Eating Disorder
  • Substance Abuse
  • Other Physiological Disorders
• Psychiatric Disorders
  • Schizophrenia
  • Psychotic Disorder
  • Dissociative Disorder
  • Obsessive Compulsive Disorder
  • Dissociative Disorder
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Other Psychiatric Disorders
• Behavioral Disorders
  • Self-Harm
  • Aggression
  • Sleep Disorder
  • Social Withdrawal
  • Dissociative Disorder
  • Hyperactivity
  • Other Behavioral Disorders
• Cognitive Disorders
  • Cognitive Impairment
  • Dementia
  • Alzheimer’s Disease
  • Other Cognitive Disorders

By Screening Method

• Self-reported Questionnaires & Surveys
  • Beck Depression Inventory (BDI)
  • Generalized Anxiety Disorder-7 (GAD-7)
  • Patient Health Questionnaire-12 (PHQ-12)
  • Hamilton Anxiety Rating Scale (HAM-A)
  • Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
  • Other Self-reported Questionnaires & Surveys
• Clinical Interviews
  • Structured Clinical Interview for DSM (SCID)
  • Mini International Neuropsychiatric Interview (MINI)
  • Diagnostic Interview for Psychological Distress (DIPD)
  • Other Clinical Interviews
• Observation-based Assessments
• Biomarker Testing

By Technology

• Self-screening mHealth Apps
• Telehealth & Virtual Care Solutions
• Continuous Monitoring Wearable Devices
• AI-based Screening Tools
• Remote Mental Health Platforms

By Age Group

• Children & Adolescents (Age 0–18 Years)
• Adults (Age 19–64)
• Seniors (Age 65 and above)

By Setting

• Clinical Settings
• Educational Institutions
• Workplace/Corporate Programs
• Online Platforms
• Other Settings

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • Rest of the Middle East & Africa

Recent Development of Mental Health Screening Industry:

• In November 2023, SonderMind (US) acquired Total Brain (US) to expand its reach, offering individualized mental wellness, supporting therapists with enhanced care techniques, providing population mental health tools for enterprises, and delivering comprehensive solutions to health plans.
• In October 2023, Ellipsis Health, Inc. (US) partnered with Augmedix (US) to introduce automated mental health screenings during patient visits.
• In December 2021, Quartet Health, Inc. (US) successfully acquired InnovaTel Telepsychiatry (US), turning its vision of rapidly delivering high-quality mental healthcare for everyone into a reality.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst